Informations:
Erreur:
Mots-clés
PISHCHEVOD ×
- Clinical Trial (11)
- Adenocarcinoma (9)
- Treatment Form (3)
- Follow-Up Studies (3)
- Registration (2)
- Routine documentation (2)
- Quality of Life (1)
- Barrett Esophagus (1)
- On-Study Form (1)
- Disease Response (1)
- Diagnostic Imaging (1)
- Hypopharynx (1)
- Medical Oncology (1)
- Neoplasms (1)
Table des matières
Modèles de données sélectionnés
Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.
13 Résultats de recherche.
Groupes Item: Header Module, Header, Disease Extent, Other Tumor Involvement, BASELINE LABS, EXAMINATIONS / CONSULTATIONS, General Conditions, Footer Module
Groupes Item: Header Module, Unnamed 1, Footer Module
Groupes Item: RTOG clinical trial administrative data, Patient status, Disease Assessment, Disease Events, New Primary, Protocol Specific Adverse Events Evaluation, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS, Footer
Groupes Item: Header Module, EQ-5D Cover Sheet, EQ-5D Health State Measurement, Health State
Groupe Item: Colon CA
Groupe Item: Hypopharynx- Esophagram findings
Groupes Item: Header Module, Summary Of Maintenance Systemic Treatment, Treatment Summary, Therapy Modification, LVEF/ Other Toxicities, Adverse Events, Comments
Groupes Item: RTOG clinical trial administrative data, Summary of Concurrent Treatment, Treatment Summary, Therapy Modification, Toxicities, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 8, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 15, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 22, PROTOCOL SPECIFIC ADVERSE EVENT EVALUATION DAY 29, Adverse Events, Comments
Groupes Item: Header Module, Header, Current Disease Status, Events, New Primary Cancer, Additional Non Protocol Treatment, Toxicities, Adverse Events, Footer Module
Groupes Item: Header Module, Header, Current Disease Status, Events, Toxicities, LVEF Status, Adverse Events, Footer Module
Groupes Item: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, FOR SWOG INSTITUTIONS, PATIENT INFORMATION, Indicate how the patient answered the following questions on the consent form, Patient Eligibility
Groupes Item: Protocol Administration, Pre-Treatment Characteristics, Certification Of Eligibility, Protocol Design (Stratification Factors), Companion Studies - Study 151007: Molecular Markers of Treatment Response (optional), Companion Studies - Study 71003: Correlation of QOL with Treatment Response and Validation of PRO-CTCAE (optional)